Dr. Hans-Josef Ritzert to Head Evonik's Chinese Business
Evonik has appointed Dr. Hans-Josef Ritzert as its regional president of greater China, effective Sept. 1. Ritzert currently heads the company's Exclusive Synthesis & Pharma Amino Acids business and was previously head of its Catalysts business. Evonik has about 3500 employees in the greater China region and had a turnover exceeding €1 billion in 2010. Ritzert, who holds a doctorate in chemistry, takes over the position from Dr. Dahai Yu, who was appointed to Evonik's executive board in April.
Dr. Jean-Luc Herbeaux will head the newly formed Health Care business line. Herbeaux, who has been leading the company's Pharma Polymers business since the beginning of 2009, joined Evonik Industries (then Degussa) in 2000.
most read
Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Valerie Diele-Braun Leaves IMCD
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Jens Birgersson Becomes New Brenntag CEO
Jens Birgersson becomes new Brenntag CEO